Home NDC 58151-137 Geodon
Product NDC 58151-137
11-digit product format 581510137
Labeler code 58151
Product ID 58151-137_8351d3a9-c9f8-4ae0-be80-ae3a4ef02820
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ziprasidone mesylate
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAMUSCULAR
Labeler Viatris Specialty LLC
Application NDA020919
Marketing category NDA
Marketing start 2025-09-09
Substance ZIPRASIDONE MESYLATE
Active strength 20 mg/mL
Pharmacologic classes Atypical Antipsychotic [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020919-001 GEODON ZIPRASIDONE MESYLATE EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N020919-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR RLD, RS 2002-06-21 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR RLD, RS 2002-06-21 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR RLD, RS 2002-06-21 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR RLD, RS 2002-06-21 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 e64feba35796…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base Geodon
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ZIPRASIDONE MESYLATE 20 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 3X6SAX83JZ Internal UNII lookup 6UKA5VEJ6X Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 10 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 284548 Internal RxNorm lookup 284549 Internal RxNorm lookup 284550 Internal RxNorm lookup 285127 Internal RxNorm lookup 313776 Internal RxNorm lookup 313777 Internal RxNorm lookup 313778 Internal RxNorm lookup 314286 Internal RxNorm lookup 351223 Internal RxNorm lookup 352228 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 58151-137-81 Geodon 10 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 10 2 58151-137-81 Geodon 1 mL in 1 VIAL INJECTION, POWDER, LYOPHILIZED, 1 2
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 58151-137-81 58151013781 10 VIAL in 1 CARTON (58151-137-81) / 1 mL in 1 VIAL 10 vial 2025-09-09 No No Current